Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluation of melatonin on insomnia and daytime sleepiness associated with COMISA
IRCT20220105053635N1Phase 3Completed
- Sponsor
- Prescribing and Rational Use of Medicines Research Center
- Start
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of melatonin in Insomnia, obstructive sleep apnea hypopnea syndrome (OSAHS) and Comorbid Insomnia and Sleep Apnea (COMISA), sponsored by Prescribing and Rational Use of Medicines Research Center. Started Apr 2022; status: completed.
02
Drugs
melatonin
03
Conditions
Insomniaobstructive sleep apnea hypopnea syndrome (OSAHS)Comorbid Insomnia and Sleep Apnea (COMISA)
Beyond the preview
Go deeper on IRCT20220105053635N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220105053635N1.